Whole genome sequencing of recombinant viruses obtained from co-infection and superinfection of Vero cells with modified vaccinia virus ankara vectored influenza vaccine and a naturally occurring cowpox virus
Modified vaccinia virus Ankara (MVA) has been widely tested in clinical trials as recombinant vector vaccine against infectious diseases and cancers in humans and animals. However, one biosafety concern about the use of MVA vectored vaccine is the potential for MVA to recombine with naturally occurr...
Main Authors: | Diana Diaz-Cánova, Ugo Moens, Annika Brinkmann, Andreas Nitsche, Malachy Ifeanyi Okeke |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1277447/full |
Similar Items
-
Genomic Sequencing and Phylogenomics of Cowpox Virus
by: Diana Diaz-Cánova, et al.
Published: (2022-09-01) -
Ophthalmic Features and Implications of Poxviruses: Lessons from Clinical and Basic Research
by: Tolulope Fashina, et al.
Published: (2022-12-01) -
Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
by: Olga Vladimirovna Orlova, et al.
Published: (2022-09-01) -
Buffalopox Virus: An Emerging Virus in Livestock and Humans
by: Kamal H. Eltom, et al.
Published: (2020-08-01) -
Gene duplication, gene loss, and recombination events with variola virus shaped the complex evolutionary path of historical American horsepox-based smallpox vaccines
by: Aline R. V. Souza, et al.
Published: (2023-10-01)